Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Netherlands Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20042
20051
20061
20073
20081
20091
20101
20113
20123
20134
20146
20152
20161
20171
20182
20193
20201
20216
20224
20231
20244
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated14
Active, not recruiting11
Recruiting9
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
Eli Lilly and Company7
European Organisation for Research and Treatment of Cancer - EORTC5
Novartis Pharmaceuticals5
AbbVie3
Pfizer3
Cell Genesys2
Sanofi2
AB Science1
AVEO Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis64
Carcinoma, Non-Small-Cell Lung11
Neoplasms11
Prostatic Neoplasms10
Melanoma9
Colorectal Neoplasms7
Breast Neoplasms6
Brain Neoplasms4
Skin Neoplasms4
Carcinoma2

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.